跳至主要内容
临床试验/NCT04514523
NCT04514523已完成不适用

QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events

Yale University6 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2020年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
6
主要终点
Acceptability - Clinicians

研究概览

简要总结

The purpose of this study is to co-develop a toolkit (known as the QBSAfe toolkit) with patients, family caregivers, and clinicians that focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety for patients with diabetes mellitus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Existing diagnosis of diabetes mellitus; have an existing appointment with a participating clinician

排除标准

  • Do not speak English
  • Severe vision/hearing impairment
  • Unable to give informed consent for any reason

结局指标

主要结局

Acceptability - Clinicians

时间窗: Baseline [Post Clinical Encounter]

Clinician responses to post-visit questionnaires.

Acceptability - Patients

时间窗: Baseline [Post Clinical Encounter]

Patient responses to post-visit questionnaires.

次要结局

  • Feasibility 2(Baseline [Post Clinical Encounter])
  • Feasibility 3(Baseline [Post Clinical Encounter])
  • Feasibility 1(Baseline [Post Clinical Encounter])

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验